Literature DB >> 8240105

Natural course of visual functions in the Bardet-Biedl syndrome.

A B Fulton1, R M Hansen, R J Glynn.   

Abstract

OBJECTIVE: To determine the course of visual functions in patients with Bardet-Biedl syndrome. PATIENTS AND METHODS: The 21 patients with Bardet-Biedl syndrome seen at Children's Hospital, Boston, Mass, had optotype and grating acuities and dark-adapted thresholds measured over time. Their ages at first visit ranged from 2 weeks to 23 years (median age, 6 years). The courses of the visual functions were analyzed with a random-effects model.
RESULTS: Substantial declines in visual functions were found. On average, grating and optotype acuities declined 0.09 log units (roughly 1 line) per year, and thresholds increased about 0.19 log units per year. The rates at which these visual functions were lost and the predicted level of the visual functions at ages 11 to 12 years (the mean ages of measurement) varied among individuals.
CONCLUSIONS: The visual prognosis for children with Bardet-Biedl syndrome is poor. The course of both central and peripheral visual functions is variable.

Entities:  

Mesh:

Year:  1993        PMID: 8240105     DOI: 10.1001/archopht.1993.01090110066026

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

1.  Development of scotopic visual thresholds in retinopathy of prematurity.

Authors:  Amber M Barnaby; Ronald M Hansen; Anne Moskowitz; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

2.  Hydrometrocolpos and polydactyly: a common neonatal presentation of Bardet-Biedl and McKusick-Kaufman syndromes.

Authors:  A David; P Bitoun; D Lacombe; J C Lambert; A Nivelon; J Vigneron; A Verloes
Journal:  J Med Genet       Date:  1999-08       Impact factor: 6.318

3.  Retinal degeneration in children: dark adapted visual threshold and arteriolar diameter.

Authors:  Ronald M Hansen; Susan E Eklund; Ilan Y Benador; Julie A Mocko; James D Akula; Yao Liu; M Elena Martinez-Perez; Anne B Fulton
Journal:  Vision Res       Date:  2007-08-31       Impact factor: 1.886

4.  Identification and functional analysis of the vision-specific BBS3 (ARL6) long isoform.

Authors:  Pamela R Pretorius; Lisa M Baye; Darryl Y Nishimura; Charles C Searby; Kevin Bugge; Baoli Yang; Robert F Mullins; Edwin M Stone; Val C Sheffield; Diane C Slusarski
Journal:  PLoS Genet       Date:  2010-03-19       Impact factor: 5.917

5.  Keeping an Eye on Bardet-Biedl Syndrome: A Comprehensive Review of the Role of Bardet-Biedl Syndrome Genes in the Eye.

Authors:  Katie Weihbrecht; Wesley A Goar; Thomas Pak; Janelle E Garrison; Adam P DeLuca; Edwin M Stone; Todd E Scheetz; Val C Sheffield
Journal:  Med Res Arch       Date:  2017-09-18

6.  Functional analysis of BBS3 A89V that results in non-syndromic retinal degeneration.

Authors:  Pamela R Pretorius; Mohammed A Aldahmesh; Fowzan S Alkuraya; Val C Sheffield; Diane C Slusarski
Journal:  Hum Mol Genet       Date:  2011-01-31       Impact factor: 6.150

7.  Visual acuity and retinal function in patients with Bardet-Biedl syndrome.

Authors:  Adriana Berezovsky; Daniel Martins Rocha; Paula Yuri Sacai; Sung Song Watanabe; Nívea Nunes Cavascan; Solange Rios Salomão
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 8.  The Kidney in Bardet-Biedl Syndrome: Possible Pathogenesis of Urine Concentrating Defect.

Authors:  Miriam Zacchia; Valentina Di Iorio; Francesco Trepiccione; Marianna Caterino; Giovambattista Capasso
Journal:  Kidney Dis (Basel)       Date:  2017-05-17

9.  Sleep and physical activity patterns in adults and children with Bardet-Biedl syndrome.

Authors:  Jeremy Pomeroy; Jeffrey J VanWormer; Jill R Meilahn; Tara Maki; Hema R Murali; Robert M Haws
Journal:  Orphanet J Rare Dis       Date:  2021-06-14       Impact factor: 4.123

10.  Bardet-Biedl syndrome-7 (BBS7) shows treatment potential and a cone-rod dystrophy phenotype that recapitulates the non-human primate model.

Authors:  Tomas S Aleman; Erin C O'Neil; Keli O'Connor; Yu You Jiang; Isabella A Aleman; Jean Bennett; Jessica I W Morgan; Brian W Toussaint
Journal:  Ophthalmic Genet       Date:  2021-03-17       Impact factor: 1.274

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.